🇦🇺 Australia market recap
Cautious2026-10-11😱 Fear is elevated, driven by Middle East shipping risks, high rates, weak earnings growth and falling housing-auction clearance rates.
Australian equities face a mixed, increasingly defensive backdrop: the RBA has lifted rates to 4.6%, while persistent inflation and weaker household demand pressure domestic growth. Energy and selected materials benefit from Middle East supply risks and copper support, but elevated bond yields and a stronger US dollar weigh on valuations. Healthcare remains comparatively resilient, while banks, retailers, property and technology face greater sensitivity to rates and earnings. ⚠️⛽🛡️
Big news
📰 RBA raises cash rate 25 basis points to 4.6%, highest level in roughly 15 years
Negative for property, discretionary retail and highly leveraged companies; supports cash, insurers and selective banks.
📰 RBA signals inflation remains stubborn despite softer household spending
Keeps tightening risk alive, limiting equity multiples and delaying relief for rate-sensitive sectors.
📰 Middle East conflict intensifies shipping risks around the Strait of Hormuz
Supports oil, LNG and energy producers while raising inflation, transport-cost and margin risks elsewhere.
📰 Brent crude trades around US$100-US$102 as supply-disruption concerns persist
Favors upstream energy and selected services; pressures airlines, transport, chemicals and consumer purchasing power.
📰 CSL signs Swiss rare-disease development deal with potential investment of about $2 billion
Strengthens healthcare innovation appeal and supports CSL’s long-term pipeline narrative despite execution risk.
📰 ASX leadership rotates toward healthcare, materials and consumer staples as banks and growth stocks weaken
Signals defensive positioning, favoring quality balance sheets and commodity exposure over domestic cyclicals.
Sector stance
Geopolitical supply risk supports oil and LNG; favor diversified producers while monitoring demand destruction.
Copper momentum helps BHP and Rio themes, but stronger US dollar and China uncertainty cap upside.
Defensive earnings and CSL’s development deal support quality healthcare, despite biotechnology volatility.
Defensive demand and pricing power favor Woolworths, Coles and Wesfarmers amid weaker household confidence.
Higher rates support margins, but credit deterioration, housing weakness and valuation risk constrain major banks.
4.6% rates, weak auction clearance and refinancing pressure remain headwinds for REITs and developers.
Debt-servicing pressure and softer spending threaten retailers; prioritize essential or market-share winners.
Elevated yields compress long-duration valuations; Firmus IPO uncertainty highlights AI infrastructure risk.
Defensive media and telecom cash flows help, but advertising sensitivity and leverage require selectivity.
Infrastructure exposure is constructive, but fuel costs, wages and weaker economic activity pressure margins.
Defensive cash flows appeal, though high bond yields reduce relative attractiveness and raise funding costs.
Outlook
Near-term leadership is likely to remain defensive, with energy, healthcare, staples and carefully selected materials outperforming rate-sensitive domestic cyclicals. A November RBA decision, inflation data, oil-shipping developments and company earnings will determine whether the market stabilizes or reprices lower. Keep portfolio duration modest, emphasize balance-sheet quality, and use weakness to accumulate defensives rather than chase speculative growth.